Literature DB >> 30076218

Hierarchical control of interleukin 13 (IL-13) signals in lung fibroblasts by STAT6 and SOX11.

Yasutaka Mitamura1,2, Satoshi Nunomura1, Yasuhiro Nanri1, Kazuhiko Arima1, Tomohito Yoshihara1, Kosaku Komiya1,3, Shogo Fukuda1, Hiroaki Takatori4, Hiroshi Nakajima4, Masutaka Furue2, Kenji Izuhara5.   

Abstract

Interleukin (IL)-13 is a signature cytokine of type 2 inflammation important for the pathogenesis of various diseases, including allergic diseases. Signal transducer and activator of transcription (STAT) 6 is a critical transcriptional factor for the IL-13 signals; however, it remains unknown how expression of the IL-13-induced genes is differentiated by the transcriptional machineries. In this study, we identified IL-13-induced transcriptional factors in lung fibroblasts using DNA microarrays in which SOX11 was included. Knockdown of SOX11 down-regulated expression of periostin and CCL26, both of which are known to be downstream molecules of IL-13, whereas enforced expression of SOX11 together with IL-13 stimulation enhanced expression of periostin. Moreover, we found that in DNA microarrays combining IL-13 induction and SOX11 knockdown there exist both SOX11-dependent and -independent molecules in IL-13-inducible molecules. In the former, many inflammation-related and fibrosis-related molecules, including periostin and CCL26, are involved. These results suggest that SOX11 acts as a trans-acting transcriptional factor downstream of STAT6 and that in lung fibroblasts the IL-13 signals are hierarchically controlled by STAT6 and SOX11.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  STAT transcription factor; allergy; cell signaling; cytokine; fibroblast; fibrosis; interleukin; transcription

Mesh:

Substances:

Year:  2018        PMID: 30076218      PMCID: PMC6153291          DOI: 10.1074/jbc.RA117.001364

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Transcription factor Sox11 is essential for both embryonic and adult neurogenesis.

Authors:  Yong Wang; Lu Lin; Helen Lai; Luis F Parada; Lei Lei
Journal:  Dev Dyn       Date:  2013-04-28       Impact factor: 3.780

Review 2.  T follicular helper and TH2 cells in allergic responses.

Authors:  Masato Kubo
Journal:  Allergol Int       Date:  2017-05-09       Impact factor: 5.836

3.  Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6.

Authors:  J Hoeck; M Woisetschläger
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

4.  Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Meifen Zhang; Rashid M Mahdi; Stephen J Kim; Igal Gery
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

5.  Characterization of the interaction between interleukin-13 and interleukin-13 receptors.

Authors:  Kazuhiko Arima; Kazuo Sato; Go Tanaka; Sachiko Kanaji; Tohru Terada; Eijiro Honjo; Ryota Kuroki; Yo Matsuo; Kenji Izuhara
Journal:  J Biol Chem       Date:  2005-05-03       Impact factor: 5.157

6.  Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling.

Authors:  Elisabeth Sock; Stefanie D Rettig; Janna Enderich; Michael R Bösl; Ernst R Tamm; Michael Wegner
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 7.  Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.

Authors:  Garry M Walsh
Journal:  Expert Rev Clin Immunol       Date:  2016-08-02       Impact factor: 4.473

8.  Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.

Authors:  Sally Wenzel; Mario Castro; Jonathan Corren; Jorge Maspero; Lin Wang; Bingzhi Zhang; Gianluca Pirozzi; E Rand Sutherland; Robert R Evans; Vijay N Joish; Laurent Eckert; Neil M H Graham; Neil Stahl; George D Yancopoulos; Mariana Louis-Tisserand; Ariel Teper
Journal:  Lancet       Date:  2016-04-27       Impact factor: 79.321

9.  Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.

Authors:  Go Takayama; Kazuhiko Arima; Taisuke Kanaji; Shuji Toda; Hiroyuki Tanaka; Shunsuke Shoji; Andrew N J McKenzie; Hiroichi Nagai; Takao Hotokebuchi; Kenji Izuhara
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

Review 10.  STAT6-dependent and -independent mechanisms in Th2 polarization.

Authors:  Elisabeth Maier; Albert Duschl; Jutta Horejs-Hoeck
Journal:  Eur J Immunol       Date:  2012-10-08       Impact factor: 5.532

View more
  6 in total

1.  Role of M2 macrophages-derived extracellular vesicles in IL-1β-stimulated chondrocyte proliferation and inflammatory responses.

Authors:  Weiwei Guo; Li Su; Hao Zhang; Zhanhu Mi
Journal:  Cell Tissue Bank       Date:  2022-06-10       Impact factor: 1.522

2.  Nuclear receptor Nr1d1 alleviates asthma by abating GATA3 gene expression and Th2 cell differentiation.

Authors:  Drishti Tiwari; Nancy Ahuja; Sumit Kumar; Rashi Kalra; Ravikanth Nanduri; Shalini Gupta; Asheesh Kumar Khare; Ella Bhagyaraj; Rashmi Arora; Pawan Gupta
Journal:  Cell Mol Life Sci       Date:  2022-05-21       Impact factor: 9.207

3.  Newborn DNA methylation and asthma acquisition across adolescence and early adulthood.

Authors:  Liang Li; John W Holloway; Susan Ewart; Syed Hasan Arshad; Caroline L Relton; Wilfried Karmaus; Hongmei Zhang
Journal:  Clin Exp Allergy       Date:  2022-01-16       Impact factor: 5.401

Review 4.  The IL-13-OVOL1-FLG axis in atopic dermatitis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Dugarmaa Ulzii; Yen Hai Vu; Makiko Kido-Nakahara; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2019-10-01       Impact factor: 7.397

Review 5.  Periostin in Allergy and Inflammation.

Authors:  Eva Sonnenberg-Riethmacher; Michaela Miehe; Dieter Riethmacher
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

6.  Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.

Authors:  Jennifer D Hamilton; Sivan Harel; Brian N Swanson; William Brian; Zhen Chen; Megan S Rice; Nikhil Amin; Marius Ardeleanu; Allen Radin; Brad Shumel; Marcella Ruddy; Naimish Patel; Gianluca Pirozzi; Leda Mannent; Neil M H Graham
Journal:  Clin Exp Allergy       Date:  2021-06-26       Impact factor: 5.018

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.